This educational dinner will focus on Journavx® (suzetrigine) for moderate to severe acute pain.
Speaker: Dr. Teresa Patel, PharmD, is a Medical Affairs professional at Vertex Pharmaceuticals with experience spanning startups to large pharma, including a focus on pediatric epilepsy and Dravet syndrome- a condition tied to a voltage-gated sodium channel mutation. Her work in this area laid the foundation for her current role supporting the launch of a first-in-class sodium channel inhibitor for acute pain. Driven by a belief that health is life’s most essential asset, she’s passionate about advancing science that helps people feel better and live an optimal life. Outside of work, she’s an avid traveler and food enthusiast who explores the world and the NYC restaurant scene! She is also passionate about caring for the planet and advocates for mindful choices that reduce our environmental impact.
There is no charge to attend, but registration is REQUIRED. Space is limited, so register early!
Copyright 2017 - Delaware Association of Nurse Anesthetists (DANA)
Contact Us | Site Map | Site by Merge Creative